1. Home
  2. PPCB vs SDST Comparison

PPCB vs SDST Comparison

Compare PPCB & SDST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPCB
  • SDST
  • Stock Information
  • Founded
  • PPCB 2007
  • SDST 2022
  • Country
  • PPCB Australia
  • SDST United States
  • Employees
  • PPCB N/A
  • SDST N/A
  • Industry
  • PPCB
  • SDST Blank Checks
  • Sector
  • PPCB
  • SDST Finance
  • Exchange
  • PPCB Nasdaq
  • SDST Nasdaq
  • Market Cap
  • PPCB 39.1M
  • SDST 34.3M
  • IPO Year
  • PPCB N/A
  • SDST N/A
  • Fundamental
  • Price
  • PPCB $2.25
  • SDST $2.72
  • Analyst Decision
  • PPCB
  • SDST Buy
  • Analyst Count
  • PPCB 0
  • SDST 2
  • Target Price
  • PPCB N/A
  • SDST $17.00
  • AVG Volume (30 Days)
  • PPCB 5.4M
  • SDST 121.1K
  • Earning Date
  • PPCB 09-30-2025
  • SDST 11-12-2025
  • Dividend Yield
  • PPCB N/A
  • SDST N/A
  • EPS Growth
  • PPCB N/A
  • SDST N/A
  • EPS
  • PPCB N/A
  • SDST N/A
  • Revenue
  • PPCB N/A
  • SDST N/A
  • Revenue This Year
  • PPCB N/A
  • SDST N/A
  • Revenue Next Year
  • PPCB N/A
  • SDST N/A
  • P/E Ratio
  • PPCB N/A
  • SDST N/A
  • Revenue Growth
  • PPCB N/A
  • SDST N/A
  • 52 Week Low
  • PPCB $0.00
  • SDST $1.43
  • 52 Week High
  • PPCB $145.46
  • SDST $125.60
  • Technical
  • Relative Strength Index (RSI)
  • PPCB N/A
  • SDST 30.44
  • Support Level
  • PPCB N/A
  • SDST $2.65
  • Resistance Level
  • PPCB N/A
  • SDST $2.90
  • Average True Range (ATR)
  • PPCB 0.00
  • SDST 0.25
  • MACD
  • PPCB 0.00
  • SDST -0.11
  • Stochastic Oscillator
  • PPCB 0.00
  • SDST 8.38

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

About SDST Stardust Power Inc. Common Stock

Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).

Share on Social Networks: